—

Vertex Pharma(VRTX)— 同类公司组

数据截至2026-10-19 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Vertex Pharma的Closelook综合评分为58/100,在同类公司组内排名第16位(共16家)——组内评分最高的是Halozyme Therapeutics Inc(74/100)。

名称综合动量质量估值信号距52周高点
VRTX Vertex Pharma58718630watch10.8%
WISE.L Wise67318156bear26.7%
DECK Deckers Outdoor66178075neutral29.9%
DXCM Dexcom66868136watch7.1%
RACE Ferrari66738327bear20.3%
LLY Eli Lilly65839128bull2.8%
TOST Toast62645144bear25%
FSLR First Solar61217374bear46.2%
REGN Regeneron61747250watch8%
GMED Globus Medical60366657watch24.3%
HDB HDFC Bank60316980neutral34.3%
DB1.DE Deutsche Börse59868139bull0.2%
HALO Halozyme Therapeutics Inc74989449ok0.5%
BION.SW BB Biotech AG73589681info15.5%
ONC BeiGene, Ltd.65836532ok4.2%
RIGL Rigel Pharmaceuticals Inc62869075info12%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-19

Quick answers

Vertex Pharma在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Wise (WISE.L)、Deckers Outdoor (DECK)、Dexcom (DXCM)、Ferrari (RACE)、Eli Lilly (LLY)、Toast (TOST)、First Solar (FSLR)、Regeneron (REGN)等。

VRTX相对同类公司的评分如何?

Vertex Pharma的综合评分为58/100,组内排名第16位(共16家),截至2026-10-19;组内最高综合评分为Halozyme Therapeutics Inc(74/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.